A R Haug

Summary

Affiliation: University of Munich
Country: Germany

Publications

  1. doi request reprint [Quantification of immunohistochemical expression of somatostatin receptors in neuroendocrine tumors using 68Ga-DOTATATE PET/CT]
    A R Haug
    Klinik und Poliklinik fur Nuklearmedizin, Klinikum der Ludwigs Maximilians Universität München, Campus Grosshadern, Marchioninistr 15, 81377, Munchen, Deutschland
    Radiologe 50:349-54. 2010
  2. doi request reprint The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University of Munich, Munich, Germany
    J Nucl Med 53:1686-92. 2012
  3. doi request reprint 18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University of Munich, Munich, Germany
    J Nucl Med 53:371-7. 2012
  4. doi request reprint [Gastroenteropancreatic neuroendocrine tumors: diagnosis and therapy in nuclear medicine]
    A R Haug
    Klinik und Poliklinik fur Nuklearmedizin, Universitätsklinikum der Ludwig Maximilians Universität München, Marchioninistrasse 15, Munich, Germany
    Internist (Berl) 53:161-6. 2012
  5. ncbi request reprint F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers
    Alexander Robert Haug
    Department of Nuclear Medicine, Ludwig Maximilians University of Munich, Germany
    J Comput Assist Tomogr 31:629-34. 2007
  6. doi request reprint Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours
    Alexander Haug
    Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany
    Eur J Nucl Med Mol Imaging 36:765-70. 2009
  7. doi request reprint 68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany
    J Nucl Med 51:1349-56. 2010
  8. doi request reprint 18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany
    Eur J Nucl Med Mol Imaging 38:1037-45. 2011
  9. doi request reprint Treatment with octreotide does not reduce tumor uptake of (68)Ga-DOTATATE as measured by PET/CT in patients with neuroendocrine tumors
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany
    J Nucl Med 52:1679-83. 2011
  10. doi request reprint Radioembolization with Yttrium-90 microspheres (SIRT) in pancreatic cancer patients with liver metastases: efficacy, safety and prognostic factors
    M Michl
    Department of Medical Oncology, Klinikum Grosshadern and Comprehensive Cancer Center, Munich, Germany
    Oncology 86:24-32. 2014

Detail Information

Publications14

  1. doi request reprint [Quantification of immunohistochemical expression of somatostatin receptors in neuroendocrine tumors using 68Ga-DOTATATE PET/CT]
    A R Haug
    Klinik und Poliklinik fur Nuklearmedizin, Klinikum der Ludwigs Maximilians Universität München, Campus Grosshadern, Marchioninistr 15, 81377, Munchen, Deutschland
    Radiologe 50:349-54. 2010
    ..The immunohistochemical expression of somatostatin receptor (SSTR) subtype 2 was compared to quantitative (68)Ga-DOTATATE PET in neuroendocrine tumors (NET)...
  2. doi request reprint The role of 68Ga-DOTATATE PET/CT in suspected neuroendocrine tumors
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University of Munich, Munich, Germany
    J Nucl Med 53:1686-92. 2012
    ..Despite recourse to several imaging modalities, the definite diagnosis of NET can be challenging. Therefore, we tested (68)Ga-DOTATATE PET/CT as a tool for improved diagnosis in a cohort of patients with suspected, nonlocalized NET...
  3. doi request reprint 18F-FDG PET/CT predicts survival after radioembolization of hepatic metastases from breast cancer
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University of Munich, Munich, Germany
    J Nucl Med 53:371-7. 2012
    ..The objective of the present study was to evaluate (18)F-FDG PET/CT for predicting survival in these patients...
  4. doi request reprint [Gastroenteropancreatic neuroendocrine tumors: diagnosis and therapy in nuclear medicine]
    A R Haug
    Klinik und Poliklinik fur Nuklearmedizin, Universitätsklinikum der Ludwig Maximilians Universität München, Marchioninistrasse 15, Munich, Germany
    Internist (Berl) 53:161-6. 2012
    ..Up to 46% of patients suffering from GEP-NET show a response to this therapy, which is able to mitigate tumour-related symptoms and significantly improve quality of life...
  5. ncbi request reprint F-18-fluoro-2-deoxyglucose positron emission tomography/computed tomography in the follow-up of breast cancer with elevated levels of tumor markers
    Alexander Robert Haug
    Department of Nuclear Medicine, Ludwig Maximilians University of Munich, Germany
    J Comput Assist Tomogr 31:629-34. 2007
    ..The value of combined positron emission tomography (PET)/computed tomography (CT) in the follow-up of patients with breast cancer with elevated tumor markers but without proven metastases or local recurrence was assessed...
  6. doi request reprint Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours
    Alexander Haug
    Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany
    Eur J Nucl Med Mol Imaging 36:765-70. 2009
    ..To compare the diagnostic impact of (68)Ga-DOTA-TATE and (18)F-DOPA PET in the diagnosis of well-differentiated metastatic neuroendocrine tumours (NET)...
  7. doi request reprint 68Ga-DOTATATE PET/CT for the early prediction of response to somatostatin receptor-mediated radionuclide therapy in patients with well-differentiated neuroendocrine tumors
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany
    J Nucl Med 51:1349-56. 2010
    ....
  8. doi request reprint 18F-FDG PET independently predicts survival in patients with cholangiocellular carcinoma treated with 90Y microspheres
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany
    Eur J Nucl Med Mol Imaging 38:1037-45. 2011
    ..We aimed to evaluate the prognostic power of FDG PET/CT and that of pretherapeutic scintigraphy with (99m)Tc-labelled macroagglutinated albumin (MAA), an index of tumour vascularization...
  9. doi request reprint Treatment with octreotide does not reduce tumor uptake of (68)Ga-DOTATATE as measured by PET/CT in patients with neuroendocrine tumors
    Alexander R Haug
    Department of Nuclear Medicine, Ludwig Maximilians University, Munich, Germany
    J Nucl Med 52:1679-83. 2011
    ..We hypothesized that (68)Ga-DOTATATE uptake of neuroendocrine tumors is sensitive to therapy with a nonradioactive somatostatin analog...
  10. doi request reprint Radioembolization with Yttrium-90 microspheres (SIRT) in pancreatic cancer patients with liver metastases: efficacy, safety and prognostic factors
    M Michl
    Department of Medical Oncology, Klinikum Grosshadern and Comprehensive Cancer Center, Munich, Germany
    Oncology 86:24-32. 2014
    ..To analyze the clinical efficacy of (90)Y radioembolization in liver metastases from pancreatic cancer, to describe treatment toxicities and to identify biomarkers as predictors of outcome...
  11. doi request reprint [Hepatic metastases in CUP (cancer of unknown primary) and painful amaurosis]
    A Klingenstein
    Augenklinik, Ludwig Maximilians Universitat Munchen, Mathildenstraße 8, 80336, Munchen, Deutschland
    Ophthalmologe 107:947-50. 2010
    ..FDG-PET/CT was able to successfully align hepatic metastases due to CUP with local ophthalmologic diagnostic findings and led to a correct diagnosis...
  12. doi request reprint Radioembolization as locoregional therapy of hepatic metastases in uveal melanoma patients
    A Klingenstein
    Department of Ophthalmology, Ludwig Maximilians University, Mathildenstraße 8, 80336, Munich, Germany
    Cardiovasc Intervent Radiol 36:158-65. 2013
    ..To retrospectively evaluate the overall survival, safety, and efficacy of metastatic uveal melanoma patients after radioembolization as salvage therapy...
  13. doi request reprint [Importance of PET/CT for imaging of colorectal cancer]
    F G Meinel
    Institut fur Klinische Radiologie, Klinikum der Ludwig Maximilians Universität München, Campus Großhadern, Marchioninistr 15, 81377, Munchen, Deutschland
    Radiologe 52:529-36. 2012
    ..Future directions and economic aspects are discussed...
  14. doi request reprint Combined anatomical and functional imaging using coronary CT angiography and myocardial perfusion SPECT in symptomatic adults with abnormal origin of a coronary artery
    C Uebleis
    Department of Nuclear Medicine, University of Munich, Marchioninistr 15, 81377 Munich, Germany
    Int J Cardiovasc Imaging 28:1763-74. 2012
    ..In a small cohort of adult symptomatic patients with ACAOS anomaly there was no relation found between the specific anatomical variant and the appearance of stress induced myocardial ischemia using cardiac hybrid imaging...